Table 2.
Selected characteristics of participants in three pooled case-control studies (CPRU Study, 1991 – 1994; MAP I Study, 1994 – 1997; and MAP II Study, 2002; pooled N = 2,751) of incident, sporadic colorectal adenoma
| Cases (N = 765) | Controls (N = 1,986) | ||||
|---|---|---|---|---|---|
| Characteristics | Mean (SD) | % | Mean (SD) | % | Pa |
| Demographics | |||||
| Age, y | 58.2 (9.2) | 54.5 (10.9) | <0.0001 | ||
| Male | 60.4 | 42.6 | <0.0001 | ||
| White | 95.0 | 96.3 | 0.17 | ||
| College graduate or higher | 28.6 | 31.8 | 0.001 | ||
| Medical history | |||||
| Takes aspirin/other NSAID ≥ once/wk | 35.6 | 41.7 | 0.003 | ||
| HRT user (among women) | 34.7 | 37.7 | 0.02 | ||
| Has family history of CRCb | 17.0 | 17.8 | 0.67 | ||
| Lifestyle | |||||
| Current smoker | 24.2 | 13.9 | <0.0001 | ||
| Normal BMIc | 32.8 | 40.9 | 0.0002 | ||
| Non-drinker | 35.7 | 32.9 | <0.0001 | ||
| Physical activityd, MET-hrs/wk | 60.5 (56.6) | 57.9 (53.7) | 0.32 | ||
| LISe | 0.4 (0.8) | 0.2 (0.8) | <0.0001 | ||
| Dietary intakes | |||||
| DISe | −0.5 (2.4) | −0.7 (2.4) | 0.02 | ||
| Total energy, kcal/day | 2,054 (747) | 1,985 (699) | 0.02 | ||
| Dietary fiber, g/1,000 kcal/day | 10.9 (3.7) | 11.3 (3.9) | 0.01 | ||
| Fat, % kcal | 31.3 (6.7) | 30.2 (6.8) | 0.0005 | ||
| Carbohydrates, % kcal | 51.2 (8.8) | 53 (8.9) | <0.0001 | ||
| Protein, % kcal | 16.4 (3.2) | 16.6 (3.1) | 0.18 | ||
| Total calciumf, mg/1,000 kcal/day | 474 (277) | 511 (272) | <0.0001 | ||
| Total fruit, servings/wk | 16.0 (12.4) | 17.8 (12.8) | 0.001 | ||
| Total vegetables, servings/wk | 25.7 (16.3) | 26.0 (16.3) | 0.65 | ||
| Red meat, servings/wk | 4.7 (3.7) | 6.1 (11.1) | 0.001 | ||
| Processed meats, servings/wk | 2.7 (3.7) | 2.1 (2.9) | <0.001 | ||
Abbreviations: BMI, body mass index; CPRU, Cancer Prevention Research Unit; CRC, colorectal cancer; DIS, dietary inflammation score; HRT, hormone replacement therapy; LIS, lifestyle inflammation score; MAP, Markers of Adenomatous Polyps; MET, metabolic equivalent; NSAID, non-steroidal anti-inflammatory drug
P-values calculated using χ2 test for categorical variables, ANOVA for continuous variables with normal distribution, and Kruskal Wallis test for continuous variables with non-normal distribution
In a first-degree relative
18.5 – 24.99 kg/m2
Moderate + vigorous physical activity
For construction of dietary and lifestyle inflammation scores, see text and Table 1; higher scores indicate a higher balance of pro- versus anti-inflammatory exposures
Total = diet + supplements